In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway. [electronic resource]
Producer: 20180330Description: E7798-E7807 p. digitalISSN:- 1091-6490
- Activins -- genetics
- Animals
- Antibodies, Neoplasm -- blood
- Antineoplastic Agents -- administration & dosage
- Autoantibodies -- blood
- B-Cell Activating Factor -- genetics
- B-Lymphocytes -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Colorectal Neoplasms -- drug therapy
- Dose-Response Relationship, Drug
- Drug Screening Assays, Antitumor
- Endoplasmic Reticulum Chaperone BiP
- Epoxide Hydrolases -- genetics
- Female
- Gene Expression
- Immunity, Humoral -- drug effects
- Immunologic Factors -- administration & dosage
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Transplantation
- Phenyl Ethers -- administration & dosage
- Piperidines -- administration & dosage
- Signal Transduction
- Tumor Burden
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.